Diagnosis: Mucous membrane pemphigoid
A 65-year-old female presented with a 6-month history of painful oral lesions and conjunctival scarring, leading to significant discomfort and impaired vision. Clinical examination revealed desquamative gingivitis with associated cicatricial changes in the conjunctiva, raising suspicion for an underlying autoimmune process.
A 65-year-old female patient presented with a 6-month history of painful oral lesions, particularly affecting her gums, and progressive vision changes due to conjunctival scarring. On examination, she exhibited erythematous, desquamative gingivitis and conjunctival scarring, contributing to her significant discomfort.Oral lesions: Erythema and desquamation of the gingiva with ulceration.Conjunctival involvement: Scarring and symblepharon formation noted during ocular examination.Systemic signs: No systemic involvement or associated autoimmune conditions reported.Other mucosal surfaces: No additional lesions observed on other mucosal surfaces during examination.
The onset of oral lesions began gradually about 6 months prior to presentation, with no identifiable triggers reported. The patient had a history of mild dry eyes but had not undergone any prior treatment for her symptoms. Her medical history was unremarkable, and there was no significant family history of autoimmune diseases. Socially, she was a retired schoolteacher and a non-smoker.Onset: Gradual onset of oral lesions over 6 months.Triggers: No known triggers or exacerbating factors identified.Prior treatments: No prior treatments attempted for oral lesions.Medical history: Unremarkable; no autoimmune diseases noted.Family history: No significant family history of autoimmune disorders.Social history: Retired, non-smoker, with no significant occupational exposures.
Acute / First-Line ManagementTopical corticosteroids (e.g., clobetasol propionate 0.05% ointment applied to affected areas twice daily).Systemic corticosteroids may be initiated for severe cases (e.g., prednisone 1 mg/kg/day with a gradual taper).Supportive care, including pain management with analgesics and oral rinses for comfort.Workup and Diagnostic ConfirmationDirect immunofluorescence microscopy of perilesional tissue to identify linear IgG and complement deposition along the basement membrane zone.Serological testing for circulating autoantibodies may be performed, including anti-BP180 and anti-BP230 antibodies.Histopathological examination of a biopsy specimen can also aid in diagnosis by revealing subepithelial blistering.Long-Term ManagementLong-term immunosuppressive therapy may be indicated for chronic cases (e.g., azathioprine 2-3 mg/kg/day or mycophenolate mofetil 1-2 g/day).Regular ophthalmologic evaluations to monitor for ocular complications and manage dry eye syndrome.Patient education regarding the chronic nature of the condition and the importance of adherence to therapy.
Stevens-Johnson Syndrome: Characterized by mucosal involvement and systemic symptoms; often precipitated by medications.Oral Lichen Planus: Presents with reticular white striae or erosive lesions; typically has a more chronic course.Behçet's Disease: Systemic vasculitis that can cause oral ulcers and ocular involvement; often accompanied by other systemic symptoms.Pemphigus Vulgaris: Presents with flaccid blisters and erosions; direct immunofluorescence shows intercellular IgG deposits.Allergic Contact Stomatitis: May mimic oral lesions but typically has a clear exposure history to allergens.Viral Infections (e.g., Herpes Simplex): Can cause oral ulcers but usually presents acutely with vesicular lesions.Desquamative Gingivitis due to other causes: Various etiologies can lead to gingival desquamation; history and biopsy may help differentiate.
High-Yield PearlsAutoimmunity: Mucous membrane pemphigoid is a chronic autoimmune blistering disorder primarily affecting mucosal surfaces.Diagnosis: Diagnosis is confirmed through direct immunofluorescence, which reveals linear IgG and complement deposition.Management: First-line treatment often involves topical corticosteroids; systemic corticosteroids may be necessary for severe cases.Ocular complications: Regular ophthalmologic assessments are crucial due to the risk of conjunctival scarring and vision impairment.Long-term care: Chronic management may require immunosuppressive therapy to prevent disease progression.Recognizing the clinical manifestations and managing mucous membrane pemphigoid promptly can prevent significant morbidity and preserve quality of life.
Tags: mucous membrane pemphigoid, cicatricial